Ajanta Pharma hits all-time high on strong Q1; surges 55% in 9 months
The pharma company has declared its first interim dividend of ₹315 crore for FY24, which translates into ₹25 per share, or 1,250%, for each ₹2 face value share.
The pharma company has declared its first interim dividend of ₹315 crore for FY24, which translates into ₹25 per share, or 1,250%, for each ₹2 face value share.